Skip to content

Clinical trials

Completed Alzheimer Disease trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Russia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20072
20082
20093
20103
20121
20133
20142
20151
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
AbbVie (prior sponsor, Abbott)3
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Eli Lilly and Company2
Hoffmann-La Roche2
AstraZeneca1
Bigespas LTD1
FORUM Pharmaceuticals Inc1
Institut de Recherches Internationales Servier1
Medivation, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease23
Dementia6
Cognitive Dysfunction3
Mental Disorders3
Nervous System Diseases3
Psychomotor Agitation3
Brain Diseases1
Central Nervous System Diseases1
Lymphoma, Follicular1
Neurodegenerative Diseases1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.